Compare DCI Indonesia Tbk (DCII) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DCI Indonesia Tbk vs Merck Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.59T), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 500 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 278.6× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| DCII | MERK | |
|---|---|---|
Market Cap | 473.59T | 1.7T |
Volume | — | 500 |
Lot | — | 5 |
Turnover | — | 1.92M |
Average Price | — | 3,842 |
Value | — | 1.92M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DCI Indonesia Tbk
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
